The Antiepileptic Lamotrigine and Its Analogues: Comparative Theoretical Electronic Properties

Structural Chemistry

Volumn 9, Issue 5, 1998, Pages 339-348

  De Oliveira Neto, Marçal ^a   Pires, José M ^b   Giambiagi, Mario ^c   De Giambiagi, Myriam Segre ^c   Alvarez, Fernando A ^d  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c CENTRO BRASILEIRO DE PESQUISAS FÍSICAS   (Brazil)

^d HOSPITAL FRANCÉS   (Argentina)

Author keywords

Lamotrigine and analogues; Molecular electrostatic potentials; Receptor binding sites

Indexed keywords

EID: 0006610687     PISSN: 10400400     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022410909843     Document Type: Article

References (51)

1. See, for example, Alvarez, F. A. In Psicofarmacologia Psicodinámica II; J. Moizeszowics, ed.; Paidós: Barcelona, 1988, p. 498.
2. Annegers, J. F. Neurol Clinics 1994, 12, 15, Epilepsy II: special issues.
3. Wise, R. A.; Chinerman, J. Exp. Neurol. 1974, 45, 355.
4. See, for example, Loew, G. H.; Nienow, J. R.; Poulsen, M. Mol. Pharmacol. 1984, 26, 19.
5. Dichter, M. A.; Brodie, M. J. N. Engl. J. Med. 1996, 334, 1583; Leppik, I. E. Epilepsia 1994, 35 (Suppl. 4), S29.
6. Dichter, M. A.; Brodie, M. J. N. Engl. J. Med. 1996, 334, 1583; Leppik, I. E. Epilepsia 1994, 35 (Suppl. 4), S29.
7. See Goa, K. L.; Ross, S. R.; Chrisp, P. Drugs 1993, 46, 152.
8. Leach, M. J.; Marden, C. M.; Miller, A. A. Epilepsia 1986, 27, 490.
9. Janes, R. W.; Lisgarten, J. N.; Palmer, R. A. Acta Cryst. 1989, C45, 129.
10. Moreau, S.; Coudert, P.; Rubat, C.; Gardette, D.; Vallee-Goyet, D.; Couquelet, J.; Bastide, P.; Tronche, P. J. Med. Chem. 1994, 37, 2153.
11. Janes, R. W.; Palmer, R. A. J. Mol. Struct. (Theochem) 1995, 339, 95.
12. Janes, R. W.; Palmer, R. A. Acta Cryst. 1995, C51, 440.
13. Janes, R. W.; Palmer, R. A. Acta Cryst. 1995, C51, 685.
14. Janes, R. W.; Palmer, R. A. Acta Cryst. 1996, C52, 2627.
15. Borea, P. A. Arzneim. Forsch. 1983, 33, 1086.
16. Kane, J. M.; Baron, B. M.; Dudley, M. W.; Sorensen, S. M.; Staeger, M. A.; Miller, F. P. J. Med. Chem. 1990, 33, 2772.
17. Mundim, K. C.; Giambiagi, M.; Giambiagi, M. S. de Nvo. Cim. D 1990, 12, 765.
18. Giambiagi, M.; Giambiagi, M. S. de; Mundim, K. C. Struct. Chem. 1990, 1, 423.
19. Stewart, J. J. P. J. Comp.-Aided Mol. Design 1990, 4, special issue, 1.
20. Hypercube Inc., 419 Phillip St., Waterloo, Ontario, Canada N2L3X2, 1994.
21. Lipkowitz, K. B.; Gilardi, R. D.; Aprison, M. H. J. Mol. Struct. 1989, 195, 65.
22. Villar, H. O.; Uyeno, E. T.; Toll, L.; Polgar, W.; Davies, M. F.; Loew, G. H. Mol. Pharmacol. 1989, 36, 589.
23. Boulanger, T.; Vercauteren, D. P.; Durant, F.; Andre, J-M. J. Theor. Biol. 1987, 127, 479.
24. Boulanger, T.; Vercauteren, D. P.; Evrard, G.; Durant, F. J. Mol. Struct. 1989, 212, 315.
25. Politzer, P.; Murray, J. S. In Reviews in Computational Chemistry, Vol. 2; K. B. Lipkowitz and D. B. Boyd, eds.; VCH: New York, 1991, p. 273.
26. Tomasi, J.; Banaccorsi, R.; Cammi, R. In Theoretical Treatment of Large Molecules and Their Interactions; Z. B. Maksic, ed.; Springer-Verlarg: Berlin, 1991, p. 230.
27. Pullman, B. In Modelling of Molecular Structure and Properties, Proceedings of an International Meeting, Nancy, France, Studies in Physical and Theoretical Chemistry, Vol. 71; J. L. Rivail, ed.; Elsevier Science Publishers B.V.: Amsterdam, 1990, pp. 1-15.
28. Desideri, A.; Polticelli, F.; Falconi, M. J. Mol. Struct. (Theochem) 1992, 256, 153.
29. Guha, S.; Majumdar, D.; Bhattacharjee, A. K. J. Mol. Struct. (Theochem) 1992, 256, 61 and references therein.
30. Loew, G. H.; Nienow, J.; Lawson, J. A.; Toll, L.; Uyeno, E. T. Mol. Pharmacol. 1985, 28, 17.
31. Tsuda, M.; Takada, T.; Miyazaki, M.; Uda, Y.; Kuzuhara, S.; Kitaura, K. J. Mol. Struct. (Theochem) 1993, 280, 261.
32. For a review, see Villar, H. O.; Davies, M. F.; Loew, G. H.; Maguire, P. A. Life Sci. 1991, 48, 593.
33. Hollinshead, S. P.; Trudell, M. L.; Skolnick, P.; Cook, J. M. J. Med. Chem. 1990, 33, 1062.
34. Tebib, S.; Bourguignon, J. J.; Wermuth, C. G. J. Comp.-Aided Mol. Design 1987, 1, 153.
35. Fryer, R. I.; Cook, C.; Gilman, N. W.; Walser, A. Life Sci. 1986, 39, 1947.
36. See Wisden, W.; Seeburg, P. H. Curr. Opin. Neurobiol. 1992, 2, 263.
37. Granger, P.; Biton, B.; Faure, C.; Vige, X.; Depoortere, H.; Graham, D.; Langer, S. Z.; Scatton, B.; Avenet, P. Mol. Pharmacol. 1995, 47, 1189.
38. Ruano, D.; Khan, Z.; De Blas, A. L.; Machado, A.; Victorica, J. Eur. J. Pharmacol., Mol. Pharmacol. Section 1994, 267, 123.
39. Faure-Halley, C.; Graham, D.; Arbilla, S.; Langer, S. Z. Eur. J. Pharmacol., Mol. Pharmacol. Section 1993, 246, 283.
40. Maguire, P. A.; Frances Davies, M.; Loew, G. H.; Eur. J. Pharmacol. 1995, 280, 167.
41. Lees, G.; Leach, M. J. Brain Res. 1993, 612, 190.
42. Pauling, L. The Nature of the Chemical Bond; Cornell University Press: Ithaca, NY, 1960, p. 520.
43. Yuen, A. W. C. Epilepsia 1994, 35 (Suppl. 5), S33.
44. Rossi, C.; Donati, A.; Bonechi, C.; Corbini, G.; Rappuoli, R.; Dreassi, E.; Corti, P. Chem. Phys. Lett. 1997, 264, 205.
45. Giambiagi, M.; Giambiagi, M. S. de; Grempel, D. R.; Heymann, C. D. J. Chim. Phys. 1975, 72, 15.
46. Giambiagi, M. S. de, Giambiagi, M.; Jorge, F. E. Z. Naturforsch. 1984, 39A, 1259.
47. Wiberg, K. Tetrahedron 1968, 24, 1083.
48. Armstrong, D. R.; Perkins, P. G.; Stewart, J. J. P. J. Chem. Soc., Dalton Trans. 1973, 838, 2273; Borisova, N. P.; Semenov, S. G. Vestn. Leningr. Univ. 1973, 16, 119.
49. Armstrong, D. R.; Perkins, P. G.; Stewart, J. J. P. J. Chem. Soc., Dalton Trans. 1973, 838, 2273; Borisova, N. P.; Semenov, S. G. Vestn. Leningr. Univ. 1973, 16, 119.
50. Giambiagi, M. S. de; Giambiagi, M.; Fortes, M. S. J. Mol. Struct. (Theochem) 1997, 391, 141.
51. Harcourt, R. D.; Sillitoe, J. F. Austral. J. Chem. 1974, 27, 691.